Breaking News

Physician turnover rates are climbing as they clamor for more work-life balance, report says

Not rendering correctly? View this email as a web page here.

Biotech IPO freeze continues as second quarter is slowest in more than a decade

By Frank Vinluan Monday, July 4, 2022 9:45 AM

Summer weather is heating up but the market for IPOs remains cold. Bausch + Lomb's successful return to the public markets in the second quarter proved to be an exception as the slowdown in IPO activity reached levels not seen in years.

Read more »

   

No comments